SOLENO THERAPEUTICS INC

Listed Company
SLNOCIK 0001484565NasdaqLarge AcceleratedPharmaceutical PreparationsDelawareFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$20.89M
Total Assets
—
Equity
—
Shares Out
52.12M
Op. Cash Flow
$46.80M
SLNO$53.02−29.33% · past yearDBEQ Basic
Daily closing prices

Business

Soleno Therapeutics is a biopharmaceutical company developing novel therapeutics for rare diseases. The company's lead product, VYKAT XR (diazoxide choline) extended-release tablets, was FDA-approved in March 2025 for treating hyperphagia in patients four years and older with Prader-Willi syndrome, and the company began recognizing revenue from VYKAT XR sales in Q2 2025. Soleno commercializes VYKAT XR through a targeted field force in the U.S. and may pursue partnerships for international markets, while manufacturing and distribution are outsourced to third-party contract manufacturing organizations and logistics providers.

Summary from 10-K filed 2026-02-25

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue—
Net income$20.89M
Total assets—
Total liabilities—
Stockholders' equity—
Operating cash flow$46.80M

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is SOLENO THERAPEUTICS INC's CIK number?

SOLENO THERAPEUTICS INC's SEC CIK number is 0001484565 (1484565). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find SOLENO THERAPEUTICS INC's SEC filings?

All of SOLENO THERAPEUTICS INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did SOLENO THERAPEUTICS INC last report earnings?

SOLENO THERAPEUTICS INC (SLNO) most recently filed an earnings 8-K with the SEC on Feb 25, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-071528). This is SOLENO THERAPEUTICS INC's most recent earnings filing of record — not a forecast of its next earnings date.

What is SOLENO THERAPEUTICS INC's most recent earnings 8-K?

SOLENO THERAPEUTICS INC's latest earnings 8-K (Item 2.02) was filed Feb 25, 2026 under accession 0001193125-26-071528. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View SOLENO THERAPEUTICS INC's latest earnings 8-K →
Look up any company's CIK number →